A broadly neutralizing human monoclonal antibody is effective against H7N9

A broadly neutralizing human monoclonal antibody is effective against H7N9

Emerging strains of influenza represent a significant public health threat with potential pandemic consequences. Of particular concern are the recently emerged H7N9 strains which cause pneumonia with acute respiratory distress syndrome. Estimates are that nearly 80% of hospitalized patients with H7N...

Full description

Bibliographic Details
Main Authors: Tharakaraman, Kannan (Contributor), Subramanian, Vidya (Contributor), Viswanathan, Karthik (Author), Sloan, Susan (Author), Yen, Hui-Ling (Author), Barnard, Dale L. (Author), Leung, Y. H. Connie (Author), Szretter, Kristy J. (Author), Koch, Tyree J. (Author), Delaney, James C. (Author), Babcock, Gregory J. (Author), Sasisekharan, Ram (Contributor), Shriver, Zachary (Author), Wogan, Gerald N (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. School of Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Wogan, Gerald N. (Contributor)
Format: Article
Language:English
Published: National Academy of Sciences (U.S.), 2016-04-04T17:15:51Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items